nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—HPGDS—testicular cancer	0.639	1	CbGaD
Dinoprost Tromethamine—SLCO3A1—Methotrexate—testicular cancer	0.0826	0.372	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Vinblastine—testicular cancer	0.031	0.14	CbGbCtD
Dinoprost Tromethamine—SLC22A2—Cisplatin—testicular cancer	0.0285	0.128	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—testicular cancer	0.0272	0.123	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—testicular cancer	0.026	0.117	CbGbCtD
Dinoprost Tromethamine—PTGFR—corpus luteum—testicular cancer	0.0177	0.387	CbGeAlD
Dinoprost Tromethamine—SLC22A8—Methotrexate—testicular cancer	0.0158	0.0713	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—testicular cancer	0.011	0.0497	CbGbCtD
Dinoprost Tromethamine—Dinoprostone—HPGDS—testicular cancer	0.0023	1	CrCbGaD
Dinoprost Tromethamine—HPGDS—embryo—testicular cancer	0.00202	0.0442	CbGeAlD
Dinoprost Tromethamine—TBXA2R—testis—testicular cancer	0.00148	0.0325	CbGeAlD
Dinoprost Tromethamine—PTGER1—female gonad—testicular cancer	0.00147	0.0322	CbGeAlD
Dinoprost Tromethamine—HPGDS—gonad—testicular cancer	0.00137	0.03	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—seminal vesicle—testicular cancer	0.00136	0.0299	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—seminal vesicle—testicular cancer	0.00135	0.0296	CbGeAlD
Dinoprost Tromethamine—PTGER3—female gonad—testicular cancer	0.00129	0.0282	CbGeAlD
Dinoprost Tromethamine—PTGER3—testis—testicular cancer	0.00114	0.025	CbGeAlD
Dinoprost Tromethamine—PTGIR—gonad—testicular cancer	0.00112	0.0245	CbGeAlD
Dinoprost Tromethamine—HPGDS—female gonad—testicular cancer	0.00111	0.0244	CbGeAlD
Dinoprost Tromethamine—TBXA2R—lymph node—testicular cancer	0.00108	0.0236	CbGeAlD
Dinoprost Tromethamine—GALR3—Peptide ligand-binding receptors—INSL3—testicular cancer	0.00104	0.0544	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—female gonad—testicular cancer	0.00103	0.0225	CbGeAlD
Dinoprost Tromethamine—HPGDS—testis—testicular cancer	0.000988	0.0216	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—gonad—testicular cancer	0.000986	0.0216	CbGeAlD
Dinoprost Tromethamine—PTGFR—testis—testicular cancer	0.000914	0.02	CbGeAlD
Dinoprost Tromethamine—PTGIR—female gonad—testicular cancer	0.000908	0.0199	CbGeAlD
Dinoprost Tromethamine—SLC22A11—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000901	0.0469	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—lymph node—testicular cancer	0.000829	0.0181	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000822	0.0428	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000817	0.0426	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—testis—testicular cancer	0.000805	0.0176	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—female gonad—testicular cancer	0.000801	0.0175	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—female gonad—testicular cancer	0.000794	0.0174	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000779	0.0406	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—testis—testicular cancer	0.000766	0.0168	CbGeAlD
Dinoprost Tromethamine—PTGIR—G alpha (s) signalling events—INSL3—testicular cancer	0.000752	0.0392	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—lymph node—testicular cancer	0.000716	0.0157	CbGeAlD
Dinoprost Tromethamine—SLCO3A1—testis—testicular cancer	0.000711	0.0156	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—testis—testicular cancer	0.000704	0.0154	CbGeAlD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000701	0.0365	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000687	0.0358	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—lymph node—testicular cancer	0.000662	0.0145	CbGeAlD
Dinoprost Tromethamine—PTGIR—lymph node—testicular cancer	0.000584	0.0128	CbGeAlD
Dinoprost Tromethamine—SLC22A6—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000573	0.0298	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000543	0.0283	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—INSL3—testicular cancer	0.000533	0.0278	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—lymph node—testicular cancer	0.000515	0.0113	CbGeAlD
Dinoprost Tromethamine—SLCO2A1—lymph node—testicular cancer	0.00051	0.0112	CbGeAlD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.00049	0.0255	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds—SLC2A6—testicular cancer	0.000478	0.0249	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000418	0.0217	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—INSL3—testicular cancer	0.000414	0.0215	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000409	0.0213	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000396	0.0206	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—INSL3—testicular cancer	0.000373	0.0194	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000371	0.0193	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000366	0.0191	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000359	0.0187	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—INSL3—testicular cancer	0.000359	0.0187	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A8—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000312	0.0163	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—INSL3—testicular cancer	0.000301	0.0157	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—STK11—testicular cancer	0.000281	0.0147	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—INSL3—testicular cancer	0.000279	0.0145	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—INSL3—testicular cancer	0.000274	0.0143	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—INSL3—testicular cancer	0.000273	0.0142	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—INSL3—testicular cancer	0.000273	0.0142	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.00026	0.0136	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—INSL3—testicular cancer	0.000234	0.0122	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—SLC-mediated transmembrane transport—SLC2A6—testicular cancer	0.000217	0.0113	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—INSL3—testicular cancer	0.000212	0.0111	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—INSL3—testicular cancer	0.000211	0.011	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000208	0.0108	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—INSL3—testicular cancer	0.000191	0.00997	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000189	0.00983	CbGpPWpGaD
Dinoprost Tromethamine—Diabetes mellitus—Epirubicin—testicular cancer	0.000168	0.00236	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Chlorambucil—testicular cancer	0.000168	0.00236	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Ifosfamide—testicular cancer	0.000167	0.00235	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Vinblastine—testicular cancer	0.000166	0.00233	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Cisplatin—testicular cancer	0.000165	0.00231	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Etoposide—testicular cancer	0.000164	0.0023	CcSEcCtD
Dinoprost Tromethamine—Hypertonia—Doxorubicin—testicular cancer	0.000163	0.00229	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Etoposide—testicular cancer	0.000163	0.00229	CcSEcCtD
Dinoprost Tromethamine—Pain—Bleomycin—testicular cancer	0.000162	0.00228	CcSEcCtD
Dinoprost Tromethamine—Chills—Etoposide—testicular cancer	0.000162	0.00227	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Doxorubicin—testicular cancer	0.000162	0.00227	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—INSL3—testicular cancer	0.000162	0.00842	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Vinblastine—testicular cancer	0.000161	0.00226	CcSEcCtD
Dinoprost Tromethamine—Infection—Ifosfamide—testicular cancer	0.000161	0.00226	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Epirubicin—testicular cancer	0.000161	0.00226	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Cisplatin—testicular cancer	0.000159	0.00223	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000159	0.00826	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—INSL3—testicular cancer	0.000158	0.00821	CbGpPWpGaD
Dinoprost Tromethamine—Phlebitis—Doxorubicin—testicular cancer	0.000157	0.0022	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Ifosfamide—testicular cancer	0.000157	0.0022	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Bleomycin—testicular cancer	0.000157	0.0022	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Doxorubicin—testicular cancer	0.000156	0.00219	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Chlorambucil—testicular cancer	0.000156	0.00219	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Doxorubicin—testicular cancer	0.000156	0.00218	CcSEcCtD
Dinoprost Tromethamine—Malaise—Cisplatin—testicular cancer	0.000155	0.00217	CcSEcCtD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—INSL3—testicular cancer	0.000154	0.00804	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—INSL3—testicular cancer	0.000154	0.00804	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Vinblastine—testicular cancer	0.000154	0.00216	CcSEcCtD
Dinoprost Tromethamine—Back pain—Etoposide—testicular cancer	0.000152	0.00213	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Ifosfamide—testicular cancer	0.000152	0.00213	CcSEcCtD
Dinoprost Tromethamine—Pain—Dactinomycin—testicular cancer	0.000152	0.00213	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Etoposide—testicular cancer	0.000151	0.00212	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Bleomycin—testicular cancer	0.00015	0.00211	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Doxorubicin—testicular cancer	0.000149	0.00209	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Vinblastine—testicular cancer	0.000149	0.00209	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Cisplatin—testicular cancer	0.000149	0.00209	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Epirubicin—testicular cancer	0.000146	0.00205	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dactinomycin—testicular cancer	0.000146	0.00205	CcSEcCtD
Dinoprost Tromethamine—Nausea—Chlorambucil—testicular cancer	0.000146	0.00205	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Ifosfamide—testicular cancer	0.000146	0.00205	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Etoposide—testicular cancer	0.000146	0.00205	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dactinomycin—testicular cancer	0.000145	0.00203	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Ifosfamide—testicular cancer	0.000145	0.00203	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Ifosfamide—testicular cancer	0.000144	0.00203	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Cisplatin—testicular cancer	0.000144	0.00202	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—INSL3—testicular cancer	0.000143	0.00745	CbGpPWpGaD
Dinoprost Tromethamine—Vomiting—Vinblastine—testicular cancer	0.000143	0.00201	CcSEcCtD
Dinoprost Tromethamine—Malaise—Etoposide—testicular cancer	0.000142	0.00199	CcSEcCtD
Dinoprost Tromethamine—Headache—Vinblastine—testicular cancer	0.000141	0.00198	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—INSL3—testicular cancer	0.00014	0.0073	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—INSL3—testicular cancer	0.00014	0.0073	CbGpPWpGaD
Dinoprost Tromethamine—Abdominal pain—Dactinomycin—testicular cancer	0.00014	0.00197	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dactinomycin—testicular cancer	0.00014	0.00197	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Bleomycin—testicular cancer	0.00014	0.00196	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Epirubicin—testicular cancer	0.000139	0.00195	CcSEcCtD
Dinoprost Tromethamine—Infection—Cisplatin—testicular cancer	0.000139	0.00195	CcSEcCtD
Dinoprost Tromethamine—Pain—Ifosfamide—testicular cancer	0.000139	0.00195	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Etoposide—testicular cancer	0.000138	0.00194	CcSEcCtD
Dinoprost Tromethamine—Cough—Etoposide—testicular cancer	0.000137	0.00192	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Cisplatin—testicular cancer	0.000137	0.00192	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Bleomycin—testicular cancer	0.000136	0.00191	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Etoposide—testicular cancer	0.000136	0.00191	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Epirubicin—testicular cancer	0.000136	0.00191	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Etoposide—testicular cancer	0.000136	0.0019	CcSEcCtD
Dinoprost Tromethamine—Diplopia—Doxorubicin—testicular cancer	0.000135	0.0019	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Cisplatin—testicular cancer	0.000135	0.0019	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Bleomycin—testicular cancer	0.000134	0.00189	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Ifosfamide—testicular cancer	0.000134	0.00188	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Etoposide—testicular cancer	0.000134	0.00188	CcSEcCtD
Dinoprost Tromethamine—Nausea—Vinblastine—testicular cancer	0.000134	0.00188	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Epirubicin—testicular cancer	0.000133	0.00187	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Ifosfamide—testicular cancer	0.000133	0.00186	CcSEcCtD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.000132	0.00689	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Etoposide—testicular cancer	0.000132	0.00185	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Cisplatin—testicular cancer	0.000131	0.00184	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Dactinomycin—testicular cancer	0.000131	0.00183	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Doxorubicin—testicular cancer	0.000129	0.00181	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Ifosfamide—testicular cancer	0.000128	0.0018	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Ifosfamide—testicular cancer	0.000128	0.0018	CcSEcCtD
Dinoprost Tromethamine—Infection—Etoposide—testicular cancer	0.000127	0.00179	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dactinomycin—testicular cancer	0.000127	0.00178	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—testicular cancer	0.000126	0.00177	CcSEcCtD
Dinoprost Tromethamine—Dehydration—Doxorubicin—testicular cancer	0.000126	0.00177	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Cisplatin—testicular cancer	0.000126	0.00176	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—INSL3—testicular cancer	0.000125	0.00653	CbGpPWpGaD
Dinoprost Tromethamine—Tachycardia—Etoposide—testicular cancer	0.000125	0.00176	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Cisplatin—testicular cancer	0.000125	0.00175	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Etoposide—testicular cancer	0.000124	0.00174	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Doxorubicin—testicular cancer	0.000123	0.00173	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dactinomycin—testicular cancer	0.000121	0.0017	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Bleomycin—testicular cancer	0.000121	0.0017	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—testicular cancer	0.00012	0.00169	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Etoposide—testicular cancer	0.00012	0.00168	CcSEcCtD
Dinoprost Tromethamine—Rash—Bleomycin—testicular cancer	0.00012	0.00168	CcSEcCtD
Dinoprost Tromethamine—Pain—Cisplatin—testicular cancer	0.00012	0.00168	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Bleomycin—testicular cancer	0.00012	0.00168	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Ifosfamide—testicular cancer	0.00012	0.00168	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Epirubicin—testicular cancer	0.000118	0.00166	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Ifosfamide—testicular cancer	0.000116	0.00163	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—testicular cancer	0.000115	0.00162	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Cisplatin—testicular cancer	0.000115	0.00162	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Etoposide—testicular cancer	0.000115	0.00162	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Ifosfamide—testicular cancer	0.000115	0.00161	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—testicular cancer	0.000115	0.00161	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Etoposide—testicular cancer	0.000114	0.0016	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Etoposide—testicular cancer	0.000114	0.0016	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—testicular cancer	0.000114	0.00159	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—INSL3—testicular cancer	0.000113	0.00589	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Bleomycin—testicular cancer	0.000113	0.00158	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Epirubicin—testicular cancer	0.000113	0.00158	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dactinomycin—testicular cancer	0.000113	0.00158	CcSEcCtD
Dinoprost Tromethamine—Rash—Dactinomycin—testicular cancer	0.000112	0.00157	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Ifosfamide—testicular cancer	0.000111	0.00156	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Cisplatin—testicular cancer	0.000111	0.00155	CcSEcCtD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—SLC2A6—testicular cancer	0.00011	0.00575	CbGpPWpGaD
Dinoprost Tromethamine—Pain—Etoposide—testicular cancer	0.00011	0.00154	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Epirubicin—testicular cancer	0.00011	0.00154	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Doxorubicin—testicular cancer	0.000109	0.00153	CcSEcCtD
Dinoprost Tromethamine—Sweating—Epirubicin—testicular cancer	0.000108	0.00152	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Epirubicin—testicular cancer	0.000107	0.00151	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Ifosfamide—testicular cancer	0.000107	0.00151	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Epirubicin—testicular cancer	0.000106	0.00149	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Etoposide—testicular cancer	0.000106	0.00148	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dactinomycin—testicular cancer	0.000105	0.00148	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Etoposide—testicular cancer	0.000105	0.00147	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Doxorubicin—testicular cancer	0.000104	0.00146	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Ifosfamide—testicular cancer	0.000103	0.00145	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Cisplatin—testicular cancer	0.000103	0.00145	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Epirubicin—testicular cancer	0.000103	0.00145	CcSEcCtD
Dinoprost Tromethamine—Rash—Ifosfamide—testicular cancer	0.000102	0.00144	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Ifosfamide—testicular cancer	0.000102	0.00144	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Etoposide—testicular cancer	0.000101	0.00142	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Etoposide—testicular cancer	0.000101	0.00142	CcSEcCtD
Dinoprost Tromethamine—Urinary tract infection—Doxorubicin—testicular cancer	0.000101	0.00142	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Cisplatin—testicular cancer	0.0001	0.00141	CcSEcCtD
Dinoprost Tromethamine—Sweating—Doxorubicin—testicular cancer	0.0001	0.0014	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Doxorubicin—testicular cancer	9.94e-05	0.0014	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Doxorubicin—testicular cancer	9.84e-05	0.00138	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—testicular cancer	9.81e-05	0.00138	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—testicular cancer	9.76e-05	0.00137	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—testicular cancer	9.7e-05	0.00136	CcSEcCtD
Dinoprost Tromethamine—Nausea—Ifosfamide—testicular cancer	9.64e-05	0.00135	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Cisplatin—testicular cancer	9.58e-05	0.00134	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Doxorubicin—testicular cancer	9.53e-05	0.00134	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Etoposide—testicular cancer	9.45e-05	0.00133	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Etoposide—testicular cancer	9.2e-05	0.00129	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Epirubicin—testicular cancer	9.18e-05	0.00129	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Epirubicin—testicular cancer	9.14e-05	0.00128	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—testicular cancer	9.1e-05	0.00128	CcSEcCtD
Dinoprost Tromethamine—Chills—Epirubicin—testicular cancer	9.08e-05	0.00127	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Etoposide—testicular cancer	9.07e-05	0.00127	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Cisplatin—testicular cancer	8.9e-05	0.00125	CcSEcCtD
Dinoprost Tromethamine—Rash—Cisplatin—testicular cancer	8.82e-05	0.00124	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Cisplatin—testicular cancer	8.82e-05	0.00124	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Etoposide—testicular cancer	8.77e-05	0.00123	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—testicular cancer	8.73e-05	0.00123	CcSEcCtD
Dinoprost Tromethamine—Back pain—Epirubicin—testicular cancer	8.52e-05	0.0012	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Doxorubicin—testicular cancer	8.49e-05	0.00119	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—testicular cancer	8.49e-05	0.00119	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Etoposide—testicular cancer	8.48e-05	0.00119	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Epirubicin—testicular cancer	8.47e-05	0.00119	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—INSL3—testicular cancer	8.46e-05	0.0044	CbGpPWpGaD
Dinoprost Tromethamine—Immune system disorder—Doxorubicin—testicular cancer	8.46e-05	0.00119	CcSEcCtD
Dinoprost Tromethamine—Chills—Doxorubicin—testicular cancer	8.4e-05	0.00118	CcSEcCtD
Dinoprost Tromethamine—Nausea—Cisplatin—testicular cancer	8.31e-05	0.00117	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—INSL3—testicular cancer	8.28e-05	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—INSL3—testicular cancer	8.28e-05	0.00431	CbGpPWpGaD
Dinoprost Tromethamine—Cough—Methotrexate—testicular cancer	8.21e-05	0.00115	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Epirubicin—testicular cancer	8.17e-05	0.00115	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—testicular cancer	8.15e-05	0.00114	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Etoposide—testicular cancer	8.15e-05	0.00114	CcSEcCtD
Dinoprost Tromethamine—Agitation—Epirubicin—testicular cancer	8.09e-05	0.00114	CcSEcCtD
Dinoprost Tromethamine—Rash—Etoposide—testicular cancer	8.08e-05	0.00113	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Etoposide—testicular cancer	8.08e-05	0.00113	CcSEcCtD
Dinoprost Tromethamine—Headache—Etoposide—testicular cancer	8.03e-05	0.00113	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—testicular cancer	8.01e-05	0.00112	CcSEcCtD
Dinoprost Tromethamine—Malaise—Epirubicin—testicular cancer	7.94e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—testicular cancer	7.92e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Syncope—Epirubicin—testicular cancer	7.9e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Back pain—Doxorubicin—testicular cancer	7.88e-05	0.00111	CcSEcCtD
Dinoprost Tromethamine—Muscle spasms—Doxorubicin—testicular cancer	7.83e-05	0.0011	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Epirubicin—testicular cancer	7.74e-05	0.00109	CcSEcCtD
Dinoprost Tromethamine—Cough—Epirubicin—testicular cancer	7.68e-05	0.00108	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Epirubicin—testicular cancer	7.63e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Infection—Methotrexate—testicular cancer	7.63e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Nausea—Etoposide—testicular cancer	7.62e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Epirubicin—testicular cancer	7.6e-05	0.00107	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Doxorubicin—testicular cancer	7.56e-05	0.00106	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Epirubicin—testicular cancer	7.5e-05	0.00105	CcSEcCtD
Dinoprost Tromethamine—Agitation—Doxorubicin—testicular cancer	7.49e-05	0.00105	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—testicular cancer	7.42e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Epirubicin—testicular cancer	7.41e-05	0.00104	CcSEcCtD
Dinoprost Tromethamine—Malaise—Doxorubicin—testicular cancer	7.35e-05	0.00103	CcSEcCtD
Dinoprost Tromethamine—Syncope—Doxorubicin—testicular cancer	7.31e-05	0.00103	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—testicular cancer	7.18e-05	0.00101	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Doxorubicin—testicular cancer	7.16e-05	0.00101	CcSEcCtD
Dinoprost Tromethamine—Infection—Epirubicin—testicular cancer	7.14e-05	0.001	CcSEcCtD
Dinoprost Tromethamine—Cough—Doxorubicin—testicular cancer	7.11e-05	0.000998	CcSEcCtD
Dinoprost Tromethamine—Shock—Epirubicin—testicular cancer	7.07e-05	0.000992	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Doxorubicin—testicular cancer	7.06e-05	0.000991	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Doxorubicin—testicular cancer	7.04e-05	0.000987	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Epirubicin—testicular cancer	7.01e-05	0.000985	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Epirubicin—testicular cancer	6.95e-05	0.000975	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Doxorubicin—testicular cancer	6.94e-05	0.000974	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—testicular cancer	6.9e-05	0.000968	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Doxorubicin—testicular cancer	6.85e-05	0.000962	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—testicular cancer	6.85e-05	0.000961	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—testicular cancer	6.83e-05	0.000958	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Epirubicin—testicular cancer	6.72e-05	0.000943	CcSEcCtD
Dinoprost Tromethamine—Infection—Doxorubicin—testicular cancer	6.61e-05	0.000927	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—testicular cancer	6.57e-05	0.000922	CcSEcCtD
Dinoprost Tromethamine—Shock—Doxorubicin—testicular cancer	6.54e-05	0.000918	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Doxorubicin—testicular cancer	6.49e-05	0.000911	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Epirubicin—testicular cancer	6.45e-05	0.000906	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Doxorubicin—testicular cancer	6.43e-05	0.000902	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Epirubicin—testicular cancer	6.41e-05	0.000899	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Epirubicin—testicular cancer	6.39e-05	0.000897	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—testicular cancer	6.33e-05	0.000888	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—testicular cancer	6.28e-05	0.000881	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Doxorubicin—testicular cancer	6.21e-05	0.000872	CcSEcCtD
Dinoprost Tromethamine—Pain—Epirubicin—testicular cancer	6.15e-05	0.000863	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—testicular cancer	6.07e-05	0.000852	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—testicular cancer	6.07e-05	0.000852	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Doxorubicin—testicular cancer	5.97e-05	0.000838	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Doxorubicin—testicular cancer	5.93e-05	0.000832	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Epirubicin—testicular cancer	5.92e-05	0.000831	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Doxorubicin—testicular cancer	5.91e-05	0.00083	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Epirubicin—testicular cancer	5.88e-05	0.000825	CcSEcCtD
Dinoprost Tromethamine—Pain—Doxorubicin—testicular cancer	5.69e-05	0.000798	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Epirubicin—testicular cancer	5.68e-05	0.000797	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Epirubicin—testicular cancer	5.68e-05	0.000797	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—testicular cancer	5.66e-05	0.000794	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Methotrexate—testicular cancer	5.51e-05	0.000773	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Doxorubicin—testicular cancer	5.48e-05	0.000769	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Doxorubicin—testicular cancer	5.44e-05	0.000763	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methotrexate—testicular cancer	5.43e-05	0.000763	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Epirubicin—testicular cancer	5.3e-05	0.000743	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Doxorubicin—testicular cancer	5.26e-05	0.000738	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Doxorubicin—testicular cancer	5.26e-05	0.000738	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—testicular cancer	5.25e-05	0.000738	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—STK11—testicular cancer	5.23e-05	0.00273	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—H2AFZ—testicular cancer	5.18e-05	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Epirubicin—testicular cancer	5.16e-05	0.000724	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—STK11—testicular cancer	5.15e-05	0.00268	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Epirubicin—testicular cancer	5.09e-05	0.000714	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—testicular cancer	5.08e-05	0.000713	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Epirubicin—testicular cancer	4.92e-05	0.00069	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Doxorubicin—testicular cancer	4.9e-05	0.000688	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—testicular cancer	4.88e-05	0.000685	CcSEcCtD
Dinoprost Tromethamine—Rash—Methotrexate—testicular cancer	4.84e-05	0.00068	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—testicular cancer	4.84e-05	0.000679	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—testicular cancer	4.81e-05	0.000675	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Doxorubicin—testicular cancer	4.77e-05	0.00067	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KITLG—testicular cancer	4.76e-05	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Epirubicin—testicular cancer	4.75e-05	0.000667	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Doxorubicin—testicular cancer	4.71e-05	0.00066	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Epirubicin—testicular cancer	4.57e-05	0.000641	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methotrexate—testicular cancer	4.56e-05	0.00064	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Doxorubicin—testicular cancer	4.55e-05	0.000639	CcSEcCtD
Dinoprost Tromethamine—Rash—Epirubicin—testicular cancer	4.53e-05	0.000636	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Epirubicin—testicular cancer	4.53e-05	0.000635	CcSEcCtD
Dinoprost Tromethamine—Headache—Epirubicin—testicular cancer	4.5e-05	0.000632	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Doxorubicin—testicular cancer	4.4e-05	0.000617	CcSEcCtD
Dinoprost Tromethamine—Nausea—Epirubicin—testicular cancer	4.27e-05	0.000599	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Doxorubicin—testicular cancer	4.23e-05	0.000593	CcSEcCtD
Dinoprost Tromethamine—Rash—Doxorubicin—testicular cancer	4.19e-05	0.000589	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Doxorubicin—testicular cancer	4.19e-05	0.000588	CcSEcCtD
Dinoprost Tromethamine—Headache—Doxorubicin—testicular cancer	4.17e-05	0.000585	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—H2AFZ—testicular cancer	4.01e-05	0.00209	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—STK11—testicular cancer	3.99e-05	0.00208	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Doxorubicin—testicular cancer	3.95e-05	0.000554	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KITLG—testicular cancer	3.69e-05	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—H2AFZ—testicular cancer	3.62e-05	0.00189	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—STK11—testicular cancer	3.6e-05	0.00187	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—FGFR3—testicular cancer	3.54e-05	0.00184	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KITLG—testicular cancer	3.33e-05	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Signaling Pathways—KIT—testicular cancer	3.25e-05	0.00169	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—FGFR3—testicular cancer	2.74e-05	0.00143	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—H2AFZ—testicular cancer	2.71e-05	0.00141	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—STK11—testicular cancer	2.69e-05	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—H2AFZ—testicular cancer	2.65e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—H2AFZ—testicular cancer	2.65e-05	0.00138	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—STK11—testicular cancer	2.63e-05	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—STK11—testicular cancer	2.63e-05	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—KIT—testicular cancer	2.52e-05	0.00131	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KITLG—testicular cancer	2.49e-05	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—FGFR3—testicular cancer	2.48e-05	0.00129	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KITLG—testicular cancer	2.44e-05	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KITLG—testicular cancer	2.44e-05	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—KIT—testicular cancer	2.27e-05	0.00118	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—HPGDS—testicular cancer	1.88e-05	0.000977	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—FGFR3—testicular cancer	1.85e-05	0.000964	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—FGFR3—testicular cancer	1.81e-05	0.000943	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—FGFR3—testicular cancer	1.81e-05	0.000943	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—KIT—testicular cancer	1.7e-05	0.000885	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—KIT—testicular cancer	1.66e-05	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—KIT—testicular cancer	1.66e-05	0.000866	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—STK11—testicular cancer	1.36e-05	0.00071	CbGpPWpGaD
